Phase 1: Activation (Weeks 14) Dose: 1.64.8 mg Daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
The Gentle Swirl: Do not shake the vial vigorously
Storage Tips Keep out of reach of children
Supporting your protocol with proper nutrition While medication potency is critical, your overall results depend on more than just the tirzepatide itself
Week-by-week Retatrutide timeline showing when results start, peak side effects (weeks 6-8), and final outcomes
On the other hand, the most common symptom associated with GLP-1 RAs is gastrointestinal symptoms, mainly nausea